Predisection Risk Factors for Vocal Cord Palsy After Total Thyroid Surgery
Recurrent Laryngeal Nerve Monitoring for the Assessment of the Vocal Cords in Thyroid Surgery
1 other identifier
observational
106
0 countries
N/A
Brief Summary
In patients undergoing total thyroidectomy, intraoperative nerve monitoring according to the International Standards Guideline Statement may detect nerves more susceptible to injury. The aim of our study was to evaluate the independent risk factors of vocal cord palsy, including those related to pre-dissection nerve monitoring values. Methods: Prospective observational study in 95 consecutive adult patients undergoing elective total thyroidectomy in Spain. A single experienced phonologist performed a videostroboscopy (VS) exam preoperatively and one week after surgery to assess vocal cord mobility. Each surgical procedure was performed with intermittent intraoperative neuromonitoring. Latency and amplitude values were obtained for the vagal and recurrent laryngeal nerves before surgical dissection and compared with the postoperative VS exam.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2014
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 16, 2021
CompletedFirst Posted
Study publicly available on registry
August 3, 2021
CompletedAugust 5, 2021
August 1, 2021
1.1 years
June 16, 2021
August 4, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
Response amplitude in recurrent laryngeal nerve in uV
Response amplitude reflects summated EMG activity from individual muscle fibers of the thyroarytenoid. We define monitoring waveform response amplitude as the height from the vertical measurement from the apex of the positive waveform deflection to the lowest point in the opposite polarity phase of the waveform ( peak to peak). Lack of signal occurred when the monitor showed low-amplitude response waves, in electromyography response (\< 100 uV), and a high-pitched warning sound.
Adult patients undergoing total thyroidectomy during a 12-month period
Response amplitude in vagal nerve in uV
Response amplitude reflects summated EMG activity from individual muscle fibers of the thyroarytenoid. We define monitoring waveform response amplitude as the height from the vertical measurement from the apex of the positive waveform deflection to the lowest point in the opposite polarity phase of the waveform ( peak to peak). Lack of signal occurred when the monitor showed low-amplitude response waves, in electromyography response (\< 100 uV), and a high-pitched warning sound.
Adult patients undergoing total thyroidectomy during a 12-month period
Vocal cord palsy
Vocal cords were assessed using videostroboscopy(Laryngeal Strobe 9400, Pentax Medical, USA) by a single experienced phonologist blinded to the neuromonitoring results
The VS exam was performed one week after surgery, through study completion, an average of 1 yearThe diagnosis of palsy (absence of motion) was made on the basis of an observation of asymmetrical laryngeal motion.
Eligibility Criteria
All consecutive adult patients undergoing total thyroidectomy during a 12-month period. All patients understood the various aspects of the study and gave written informed consent.
You may qualify if:
- To be at least 18 years old, to accept participation in the study, and to be scheduled for a total bilateral thyroidectomy.
You may not qualify if:
- Urgent thyroidectomy, inability to perform videostroboscopy, minor patients, patient refuse to be part of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Enric Caubet
Hospital Vall d'Hebron , Barcelona. Spain
- STUDY CHAIR
Marcos De Miguel
Hospital Vall d'Hebron , Barcelona. Spain
- STUDY DIRECTOR
Oscar González
Hospital Vall d'Hebron , Barcelona. Spain
- STUDY CHAIR
Mercedes Velasco, Ph
Hospital Universitari Vall d'Hebron Research Institute
- STUDY CHAIR
Miriam De Nadal
Hospital Vall d'Hebron , Barcelona. Spain
- PRINCIPAL INVESTIGATOR
Eva Pelaez
Hospital Vall d'Hebron , Barcelona. Spain
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 16, 2021
First Posted
August 3, 2021
Study Start
April 1, 2014
Primary Completion
May 1, 2015
Study Completion
December 1, 2015
Last Updated
August 5, 2021
Record last verified: 2021-08